Heterologous anti-lymphocyte sera were demonstrated to induce a cytotoxic potential in normal non-immunized human lymphocytes against allogeneic fibroblast target cells. The cytotoxicity-inducing capacity was restricted to certain dilutions of anti-lymphocytic serum above and below which no cytotoxic effect was obtained. This optimal concentration shifted towards higher dilutions in sera taken late during the immunization course. The antisera were shown to stimulate the DNA-synthesis in lymphocytes and to aggregate the lymphocytes to the target cells. The DNA-synthesis and the aggregation as well were maximal at the same dilution of anti-lymphocytic serum which induced cytotoxicity. No cytotoxic effect was demonstrable on sheep fibroblasts. It is, therefore, suggested that the anti-lymphocytic serum antibody induces lymphocyte-mediated cytotoxicity against allogeneic fibroblasts in a two step manner: it stimulates the lymphocytes into a cytotoxic state; it aggregates the human lymphocytes to the human fibroblasts by virtue of its bivalent structure. Anti-lymphocytic serum was also found to suppress the cytotoxic activity of lymphocytes induced by various non-specific agents, such as phytohaemagglutinin, streptolysin O and anti-lymphocytic serum itself. The mechanism for this inhibition is extensively discussed and it is suggested that anti-lymphocytic serum suppresses the reaction by coating the lymphocytes, thereby preventing the intimate contact between effector and target cell. A similar mechanism may operate and could be a partial explanation of the immunosuppressive effect of anti-lymphocytic serum. Purified 7S γ-globulin possessed all activities of the whole antiserum.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1579123PMC

Publication Analysis

Top Keywords

anti-lymphocytic serum
28
human lymphocytes
12
cytotoxic activity
8
lymphocytes
8
heterologous anti-lymphocyte
8
serum
8
target cells
8
suggested anti-lymphocytic
8
anti-lymphocytic
7
cytotoxic
6

Similar Publications

Immunosuppression in liver and intestinal transplantation.

Best Pract Res Clin Gastroenterol

December 2021

Department General Surgery, Liver, Pancreas and Intestinal Transplantation, Hospital Universitario, Fundacion Favaloro, Buenos Aires, Argentina.

Immunosuppression handling plays a key role in the early and long-term results of transplantation. The development of multiple immunosuppressive drugs led to numerous clincial trials searching to reach the ideal regimen. Due to heterogeneity of the studied patient cohorts and flaws in many, even randomized controlled, study designs, the answer still stands out.

View Article and Find Full Text PDF

Objective: The aim of the study is to evaluate whether intra-operative induction with anti-lymphocytic serum (ALS) is superior to no induction in adult liver transplantation (LT).

Background: The efficacy of ALS induction remains inconclusive in LT, because of poorly designed trials.

Methods: A randomized controlled trial was conducted, including 206 adults (>15 years) and comparing tacrolimus monotherapy (TAC, n = 109) and tacrolimus plus a single, intraoperative, high-dose (9 mg/kg), rabbit anti-T-lymphocyte globulins (ATLG; n = 97).

View Article and Find Full Text PDF

T-cell vaccination (TCV), the application of irradiated activated T cells, has been shown to prevent effectively and treat experimental autoimmune diseases. It has been reported that anti-lymphocytic antibodies induced by TCV were capable of strongly inhibiting T-cell proliferation and of ameliorating experimental autoimmune disease. The present study was undertaken to characterize the antigen specificity of these Abs.

View Article and Find Full Text PDF

The adjusted relative risk (aRR) for development of post-transplant lymphoproliferative disorder (PTLD) is higher in kidney transplant recipients receiving monoclonal antibody induction therapy, but the aRR between the different available polyclonal agents has not been investigated in detail. We analyzed data from the United Network of Organ Sharing registry on all kidney transplants performed between 1987 and 2003. The aRR for PTLD development was calculated using SAS 9.

View Article and Find Full Text PDF

Polyomavirus nephropathy: morphology, pathophysiology, and clinical management.

Curr Opin Nephrol Hypertens

November 2003

Department of Pathology, Nephropathology Laboratory, The University of North Carolina, Chapel Hill, North Carolina 27599-7525, USA.

Purpose Of Review: Viral nephropathies, particularly those caused by polyomaviruses of the BK-virus strain, are serious complications following renal transplantation. The review will highlight the morphological, pathophysiological and clinical aspects of BK-virus nephropathy. New patient management strategies are discussed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!